Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Farckhutdinov, L. Abdrachmanova, A. Mirchaidarov, R. Zakirova (Ufa, Russian Federation). The state of patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2007; 30: Suppl. 51, 3272

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Prevelance of anemia in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007